Da En
Da / En

Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment

a randomised, controlled trial

Casper Steenholdt , Jørn Brynskov , Ole Østergaard Thomsen , Lars Kristian Munck , Jan Fallingborg , Lisbet Ambrosius Christensen , Gitte Pedersen , Jens Kjeldsen , Bent Ascanius Jacobsen , Anne Sophie Oxholm , Jakob Kjellberg , Klaus Bendtzen & Mark Andrew Ainswort